loader
Delivery Location

Ganciclovir 250mg

CAS# 82410-32-0

Grade: HPLC-UV

SKU: ChemD-976-S1878-250mg-1x250-Milligram-82410-32-0

Product Overview

In stock
Purity
97%
Size
1x250 Milligram
Container Type
Vial
Est Delivery Date
Price per Unit
Tooltip icon
Quantity
Price per Unit
Tooltip icon
Quantity
Document Links
SDS Document
Form
Not Specified
Density
-
Appearance & Physical State
-
Color
-
Odor
-
Melting Point
250 dec °C
Boiling Point
-
Freezing Point
250 dec °C
Molecular Weight
255.23
Flash Point
-
pH value
-

Have a question regarding this product?

Contact Us

Shop all of the products from this supplier?

View Supplier Storefront
Country of Manufacture
-
Refractive Index
-
LogP
-2.5
Exact/Molecular Mass
255.09675391 g/mol
Molar mass
-
Concentration
-
Water Content
-
Acid Content
-
Viscosity
-
Cloud Point
-
Specific heat of liquid
-
Thermo Stability
-
Oxygen Stability
-
Water Stability
-
Vapor Pressure
-
Assay (Gas chromatography)
-
Molecular formula
C9H13N5O4
Soluble
>38.3 [ug/mL] (The mean of the results at pH 7.4)
Max Handling Temp
-
Recommended Dosage
-

Ganciclovir 250mg for Sale Online

Selleck Chemicals LLC manufactures Ganciclovir 250mg, for sale through ChemDirect.
Selleck Chemicals LLC sells Ganciclovir 250mg with a product grade of HPLC-UV and percent purity of 97%. Ganciclovir 250mg is for sale online in 1x10 Millimeter, 1x250 Milligram, and 1x50 Milligram quantities. Ganciclovir 250mg has the molecular formula C9H13N5O4 and a chemical weight of 255.23. Ganciclovir 250mg is also called cytovene, gancyclovir, vitrasert, zirgan, hydroxyacyclovir, rs-21592, ganciclovirum, cymevene, bw-759u, hhemg and virgan. It's CAS (Chemical Abstracts Service) Registry Number is 82410-32-0.

Save time and money when you buy Ganciclovir 250mg online through ChemDirect.

About the Supplier

Selleck Chemicals LLC Selleck Chemicals supplies over 120,000 inhibitors used in the study of cell signaling pathways. They actively track the latest science so their customers can rely on us to be the leading supplier of the newest inhibitors